ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,715Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 97

$464K Total Retail Price of All Prescriptions

Rank: 29 out of 97

363 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 363 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 363 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 9,640 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
FUROSEMIDE 646 609 1 3
SIMVASTATIN 469 430 2 2
METOPROLOL TARTRATE 415 396 3 7
LEVOTHYROXINE SODIUM 394 364 4 1
LOSARTAN POTASSIUM 359 351 5 13
AMLODIPINE BESYLATE 357 353 6 6
OMEPRAZOLE 321 297 7 5
HYDROCHLOROTHIAZIDE 279 269 8 9
METOPROLOL SUCCINATE 248 225 9 8
LISINOPRIL 228 174 10 4
HYDROCODONE-ACETAMINOPHEN 225 160 S3 11 17
ENALAPRIL MALEATE 222 210 12 47
WARFARIN SODIUM 221 208 13 11
POTASSIUM CHLORIDE 216 200 14 10
SERTRALINE HCL 195 188 15 16
GABAPENTIN 171 153 16 18
METFORMIN HCL 165 161 17 12
ZOLPIDEM TARTRATE 116 111 18 32
DIGOXIN 114 107 19 26
ATENOLOL 110 99 20 15
ISOSORBIDE MONONITRATE ER 100 94 21 27
PREDNISONE 96 83 22 23
LANTUS 96 94 22 43
SEROQUEL 90 89 24 142
TRIAMTERENE-HCTZ 89 89 25 30
MORPHINE SULFATE ER 87 42 S2 26 137
POLYETHYLENE GLYCOL 3350 83 72 27 55
QUETIAPINE FUMARATE 83 74 27 82
AZITHROMYCIN 82 70 29 64
MIRTAZAPINE 79 79 30 35
FELODIPINE ER 77 73 31 128
CARBIDOPA-LEVODOPA 77 74 31 61
ALENDRONATE SODIUM 75 72 33 19
CITALOPRAM HBR 70 66 34 20
CARVEDILOL 66 66 35 25
HUMALOG 65 63 36 77
ALLOPURINOL 65 59 36 22
TRAZODONE HCL 63 56 38 42
FENTANYL 61 49 S2 39 50
TRAMADOL HCL 61 49 39 21
AMITRIPTYLINE HCL 61 48 R 39 54
ATORVASTATIN CALCIUM 60 55 42 14
FAMOTIDINE 59 59 43 105
CIPROFLOXACIN HCL 58 48 44 60
NAMENDA 56 56 45 38
LOVASTATIN 56 56 45 62
TERAZOSIN HCL 54 54 47 106
LANTUS SOLOSTAR 54 48 47 41
OXCARBAZEPINE 53 53 49 226
DIPYRIDAMOLE 53 53 R 49 226
CRESTOR 53 53 49 29
ACETAMINOPHEN-CODEINE 50 42 S3 52 145
RAMIPRIL 50 50 52 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 31, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.